Article Text
Statistics from Altmetric.com
- Treatment surgery
- cornea
- conjunctiva
- public health
- lens and zonules
- epidemiology
- orbit
- eye lids
- public health
We read the article entitled ‘A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis’ by Wilkins and colleagues1 with great interest. Although viral conjunctivitis is typically a self-limiting disease that resolves in 2 weeks, we agree that an agent that reduces clinical symptoms and minimises shedding of infectious virus would be desirable given the morbidity and potential economic impact associated with an outbreak of viral conjunctivitis.2 We have the following observations regarding the methodology and interpretation of the results.
Eighty-eight out of 111 randomised patients returned for review, that is, …
Footnotes
Funding The authors received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None.
Provenance and peer review Not commissioned; internally peer reviewed.